Larimar Therapeutics, Inc. (LRMR) Social Stream
LARIMAR THERAPEUTICS INC (LRMR) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering LARIMAR THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 3 | $26.43 | $19 | $22.715 | $4.65 | 388.49% |
| 2022-02-15 | 2 | $26.43 | $3 | $14.715 | $4.65 | 216.45% |
| 2022-05-12 | 2 | $3 | $3 | $3 | $4.65 | -35.48% |
| 2022-09-19 | 3 | $16 | $16 | $16 | $4.65 | 244.09% |
| 2022-09-20 | 3 | $16 | $10 | $13 | $4.65 | 179.57% |
| 2022-11-11 | 4 | $16 | $10 | $12.666 | $4.65 | 172.39% |
| 2023-02-10 | 5 | $16 | $4 | $10.5 | $4.65 | 125.81% |
| 2023-05-15 | 5 | $16 | $4 | $11.5 | $4.65 | 147.31% |
| 2023-05-16 | 5 | $15 | $4 | $11.25 | $4.65 | 141.94% |
| 2023-08-10 | 5 | $15 | $4.5 | $11.375 | $4.65 | 144.62% |
| 2023-08-15 | 5 | $17 | $4.5 | $11.833 | $4.65 | 154.47% |
| NA | 2 | $NA | $NA | $NA | $4.65 | NA% |
The Trend in the Analyst Price Target
LRMR's average price target has moved up $2.52 over the prior 46 months.
LRMR reports an average of 168.37% for its upside potential over the past 27 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-01 | 5 | 16 | 4.0 | 11.500 | 5.82 | 97.59% |
| 2023-05-15 | 5 | 16 | 4.0 | 11.500 | 3.59 | 220.33% |
| 2023-05-16 | 5 | 15 | 4.0 | 11.250 | 3.65 | 208.22% |
| 2023-05-18 | 5 | 15 | 4.5 | 11.375 | 3.77 | 201.72% |
| 2023-08-15 | 5 | 17 | 4.5 | 11.833 | 4.18 | 183.09% |
LRMR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 153 days, LRMR's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LRMR as an investment opportunity.
- LRMR has a greater number of analysts covering the stock than 196.3% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, LARIMAR THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1224.17% of them.
- In terms of how LARIMAR THERAPEUTICS INC fares relative to all US stocks, note that its average analyst price target is higher than 246.3% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, LARIMAR THERAPEUTICS INC's variance in analysts' estimates is lower than -561.26% of them.
In the Pharmaceutical Products industry, ALDX, IMUX, and KURA are the three stocks most similar to LARIMAR THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is LRMR a Buy, Hold or Sell? See the POWR Ratings now!